Flash Sale 70% Off
Give customers details about the banner image(s) or content on the template.
Research Peptide
Growth hormone releasing hormone (GHRH) analogue peptide. Classification Long-acting growth hormone releasing hormone (GHRH) analogue. CJC-1295 belongs to a ...
$90.00
Growth hormone releasing hormone (GHRH) analogue peptide.
Classification
Long-acting growth hormone releasing hormone (GHRH) analogue. CJC-1295 belongs to a class of peptides designed to stimulate the body’s natural production of growth hormone through activation of the growth hormone axis. It is commonly researched for its ability to promote sustained growth hormone and IGF-1 signaling without directly supplying exogenous growth hormone.
Target Receptors
• GHRH Receptor – Located primarily within the anterior pituitary gland and responsible for stimulating growth hormone secretion.
Structure
CJC-1295 is a modified analogue of naturally occurring GHRH. The peptide contains structural modifications designed to improve stability and significantly extend its duration of activity compared to native GHRH.
Research Focus
Studied for its potential effects on growth hormone secretion, IGF-1 production, body composition, recovery, and lean tissue development.